Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | ALPG | P10696 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | PLEC | Q15149 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 14/20 | 0.53 |
| ▸ | CA1 | P00915 | 12/20 | 0.53 |
| ▸ | CA2 | P00918 | 12/20 | 0.53 |
| ▸ | CA12 | O43570 | 4/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.53 |
| ▸ | CA7 | P43166 | 3/20 | 0.52 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | ALB | P02768 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20256560 | 0.93 | USP2 (0.59) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20056705 | 0.89 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL10060092 | 0.87 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL23158776 | 0.85 | USP2 (0.56) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL13369020 | 0.85 | USP2 (0.75) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14619875 | 0.85 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL18383481 | 0.84 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL29668458 | 0.84 | USP2 (0.68) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL19449068 | 0.83 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL10026007 | 0.83 | USP2 (0.72) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207423-A1 | PROGAMMABLE POLYMERIC DRUGS | SONY GROUP CORP (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230012304-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | Sony Group Corporation (JP) | 2023-01-12 | — | — | US | disclosed |
| US-20210340380-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | Sony Group Corporation (JP) | 2021-11-04 | — | — | US | disclosed |
| US-20210128739-A1 | PROGRAMMABLE POLYMERIC DRUGS | Sony Group Corporation (JP) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128739-A1 | PROGRAMMABLE POLYMERIC DRUGS | CHRM1, PBRM1, MRPL21 | USP2 2155/4885L3MBTL1 11/4885MEN1 96/4885 |
| US-20240207423-A1 | PROGAMMABLE POLYMERIC DRUGS | OPRM1, CHRM1, TUBB3 | USP2 3217/4885L3MBTL1 444/4885MEN1 371/4885 |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | IK, MTCL3, RRM1 | USP2 699/4885L3MBTL1 27/4885MEN1 1209/4885 |
| US-20230012304-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, MTCL3, TMT1A | USP2 2719/4885L3MBTL1 22/4885MEN1 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.